Yashraj Biotechnology Ltd, (YBL) is 100% EOU and manufacturer of various Native antigen, recombinant and cell derived antigens, and polyclonal and monoclonal antibodies. Since 2017 company has also ventured into development of induced pluripotent Native antigens for drug discovery and other potential applications. Company encourages and facilitates the creation, discovery, dissemination and application of new knowledge through its unit, and academic alliance initiatives.
Company was established in 1999 and has a total staff strength of over 250 employees, engaged in Production, Research & Development, Quality Control etc.